Apogee Therapeutics (APGE) Retained Earnings (2022 - 2026)
Apogee Therapeutics (APGE) reported Retained Earnings of -$749000.0 for Q1 2026, down 169.74% year-over-year from $1.1 million in Q1 2025, and down 169.35% on a QoQ basis from $1.1 million in Q4 2025.
Apogee Therapeutics (APGE) has 5 years of Retained Earnings data on file, last reported at -$749000.0 in Q1 2026.
- Quarterly Retained Earnings fell 169.74% year-over-year to -$749000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$749000.0 (down 169.74% YoY) and the FY2025 annual result came in at $1.1 million, up 18.03% from the prior year.
- Retained Earnings retreated to -$749000.0 in Q1 2026 per APGE's latest filing, from $1.1 million in the prior quarter.
- Across five years, Retained Earnings topped out at $1.1 million in Q4 2025 and bottomed at -$492.4 million in Q3 2025.
- The 5-year median for Retained Earnings is -$71.2 million (2023), against an average of -$131.1 million.
- The widest annual swing landed in 2024, when Retained Earnings surged 178.12%; it then slumped 169.74% in 2026.
- Tracing APGE's Retained Earnings over 5 years: stood at -$39.8 million in 2022, then soared by 100.83% to $329000.0 in 2023, then surged by 178.12% to $915000.0 in 2024, then increased by 18.03% to $1.1 million in 2025, then sank by 169.35% to -$749000.0 in 2026.
- Per Business Quant, the three latest APGE Retained Earnings figures stand at -$749000.0 (Q1 2026), $1.1 million (Q4 2025), and -$492.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Apogee Therapeutics | 5.53 Bn | 4.47 Bn | - | -749,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -749,000.00 |
| Dec 31, 2025 | 1.08 Mn |
| Sep 30, 2025 | -492.40 Mn |
| Jun 30, 2025 | -427.40 Mn |
| Mar 31, 2025 | 1.07 Mn |
| Dec 31, 2024 | 915,000.00 |
| Sep 30, 2024 | -238.70 Mn |
| Jun 30, 2024 | -189.70 Mn |
| Mar 31, 2024 | -155.86 Mn |
| Dec 31, 2023 | 329,000.00 |
| Sep 30, 2023 | -92.04 Mn |
| Jun 30, 2023 | -71.20 Mn |
| Dec 31, 2022 | -39.79 Mn |